This inventor holds 4 USPTO granted patents. Top assignees: Xoma Corporation, Xoma Technology Ltd.. Active years: 1991-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2002
Title: Changtung Paul Chang: Innovator in Chimeric Antibody Production
Introduction
Changtung Paul Chang, based in Chatsworth, CA, is a notable inventor with a focus on the development of chimeric antibodies. With a total of four patents to his name, he has made significant contributions to the field of immunology, especially in recognizing human tumor antigens. His work showcases the intersection of science and innovation, providing new avenues for cancer treatment.
Latest Patents
Among his recent innovations, one of the notable patents is titled "Production of Chimeric Antibodies with Specificity to Human Tumor Antigens." This invention focuses on chimeric immunoglobulins that can recognize human tumor antigens bound by antibodies ING-2, ING-3, ING-4, or KM10. It encompasses not only the production of such immunoglobulins but also their applications in therapeutic settings.
Another significant patent by Chang is "Production of Chimeric Mouse-Human Antibodies with Specificity to Human." This invention pertains to a chimeric immunoglobulin that recognizes the human tumor antigen associated with the antibody ING-1, emphasizing its production process and therapeutic use.
Career Highlights
Changtung Paul Chang has had a prominent career with key positions in renowned companies, particularly at Xoma Corporation and Xoma Technology Ltd. His expertise and innovative spirit have played a crucial role in advancing the technologies developed in these organizations.
Collaborations
Throughout his career, Chang has collaborated with distinguished colleagues, including Arnold H. Horwitz and Marc D. Better. These collaborations have undoubtedly facilitated the progression and refinement of his research, enabling him to produce impactful innovations in the field of chimeric antibodies.
Conclusion
Changtung Paul Chang is a significant figure in the realm of immunology and antibody research. His innovative patents and collaborations reflect his dedication to advancing cancer treatment technologies. As he continues to contribute to the scientific community, his work holds promise for revolutionizing therapeutic strategies against human tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile